LMNA and progeroid syndrome: RNAi screening controls consisted of fibroblasts in which GFP-progerin expression was induced by doxycycline treatment, in the presence of 1) a non-targeting control siRNA, which allowed for full expression of GFP-progerin and formation of a progeria-like cellular phenotype in most cells, and from here on will be referred to as the GFP-progerin expressing control, or 2) a GFP-targeting siRNA, which eliminated GFP-progerin, restored a healthy-like phenotype, and from here on will be referred to as the GFP-progerin repressed control.